Science and development
Analytical similarity, totality of evidence, clinical strategy, immunogenicity and global development choices.
Philadelphia · September 21–23, 2027
Global biosimilars conference for science, access and commercial strategy.
PARITY 2027 brings the full biosimilars equation into one room—from analytical similarity and regulatory pathways to manufacturing, pricing, reimbursement, adoption, licensing and investment.
Why PARITY
Biosimilar success is a system-wide challenge.
A technically successful biosimilar still depends on reliable manufacturing, workable regulatory strategy, freedom to operate, competitive pricing, payer alignment, provider confidence, patient acceptance and a commercial model that creates sustainable value.
PARITY is designed to connect those decisions rather than examine them in isolation. The conference gives developers, manufacturers, payers, regulators, providers, investors and partners a shared environment for understanding where biosimilar opportunity is emerging—and what can prevent adoption.
Conference focus
Across the biosimilars lifecycle.
Regulatory and legal strategy
Interchangeability, global pathway convergence, exclusivity, patent strategy, litigation and freedom to operate.
Manufacturing and supply
Process development, scale-up, technology transfer, CDMO strategy, capacity and resilient commercial supply.
Pricing and market access
Reimbursement, contracting, formularies, Medicare policy, Maximum Fair Price implications and payer decision-making.
Adoption and commercialization
Provider confidence, patient communication, substitution, launch sequencing, channel strategy and uptake.
Licensing and investment
Portfolio strategy, regional rights, transaction structures, diligence, capital allocation and partnership models.
Who should attend
Every stakeholder who influences biosimilar outcomes.
- Biosimilar developers, manufacturers and originator companies
- Regulatory, legal, IP and clinical-development leaders
- Market-access, pricing, payer and reimbursement teams
- Providers, health systems, pharmacists and policy makers
- CDMOs, supply partners and technology organizations
- Business-development, licensing, investment and portfolio teams
Event details
PARITY 2027 at a glance.
DatesSeptember 21–23, 2027
VenueThe Logan Philadelphia Hotel
LocationOne Logan Square, Philadelphia, PA 19103
What is PARITY 2027?
PARITY is a global biosimilars conference connecting scientific, regulatory, manufacturing, market-access, pricing, commercial, licensing, policy and investment perspectives in one event.
Who should attend the biosimilars conference?
PARITY is designed for biosimilar developers and manufacturers, CDMOs, regulators, payers, providers, market-access teams, commercial leaders, licensing executives, investors and policy makers.
Does PARITY cover biosimilar pricing and adoption?
Yes. Pricing, reimbursement, formulary strategy, interchangeability, substitution, provider and patient confidence, Medicare policy and commercial adoption are core parts of the programme.
Where equivalence meets opportunity
Join the leaders shaping the next era of biosimilars.
Review delegate options, explore the agenda and meet the confirmed PARITY faculty.